Vident Advisory, LLC

Position in RDY — Dr Reddys Laboratories Ltd

CIK 1744347 Alpharetta, GA

Position in RDY

as of Jun 30, 2026 · filed Aug 12, 2026 Compact

Position Value

$2,714,150

-$299,346 QoQ

Shares Held

187,312

-13.9% QoQ

Ownership

0.022%

of shares outstanding

% of Portfolio

0.02%

of 13F equity value

Holder Rank

#48

of 238 holders

Holding Since

Sep 2023

12 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Vident Advisory, LLC holds $34,283,611 across 24 Drug Manufacturers - Specialty & Generic names. RDY ranks #4 (7.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VTRS	Viatris Inc	317,141	$5,036,196
2	ALKS	Alkermes plc.	84,111	$4,407,415
3	UTHR	UNITED THERAPEUTICS Corp	6,535	$3,540,857
4	RDY	Dr Reddys Laboratories Ltd This page	187,312	$2,714,150
5	ZTS	Zoetis Inc.	33,892	$2,435,477
6	TAK	Takeda Pharmaceutical Co Ltd	143,921	$2,307,052
7	NBIX	Neurocrine Biosciences Inc	13,348	$2,249,670
8	HLN	Haleon plc	214,226	$1,998,728

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$2,714,150	187,312	-13.9%	Shares	Defined	2026-08-12
2026-03-31	$3,013,496	217,581	+4.2%	Shares	Defined	2026-05-15
2025-12-31	$2,930,807	208,747	+8.1%	Shares	Defined	2026-02-18
2025-09-30	$2,698,992	193,061	+2.0%	Shares	Defined	2025-11-14
2025-06-30	$2,844,713	189,269	+18.3%	Shares	Defined	2025-08-14
2025-03-31	$2,110,756	160,027	+5.7%	Shares	Defined	2025-05-15
2024-12-31	$2,389,516	151,331	+535.5%	Shares	Defined	2025-02-14
2024-09-30	$1,891,942	23,813	+0.3%	Shares	Defined	2024-11-14
2024-06-30	$1,809,587	23,751	+3.5%	Shares	Defined	2024-08-14
2024-03-31	$1,682,722	22,941	+3.7%	Shares	Sole	2024-05-14
2023-12-31	$1,539,317	22,123	+15.5%	Shares	Sole	2024-02-14
2023-09-30	$1,281,295	19,161	—	Shares	Sole	2024-02-21
No filing history on record for this holder in this stock.